CME, NYSE Owner Lobby Washington to Regulate Hyperliquid Over Manipulation and Sanctions Fears
CME and the owner of the New York Stock Exchange are pressing Washington to scrutinize Hyperliquid over manipulation and sanctions concerns. That fact alone is loud. A decentralized derivatives venue is now big enough to irritate the old exchange operators, and HYPE, Hyperliquid’s native token, fell about 6% after Bloomberg reported the lobbying effort, dropping from above $45 to below $43. My take: this is not just about one exchange. It is about who gets to shape crypto price discovery.
Bloomberg reported that CME Group and Intercontinental Exchange, or ICE, which owns the NYSE, have pushed US authorities to regulate Hyperliquid. Their concern is direct: Hyperliquid operates mostly offshore, with lighter oversight than US derivatives venues, and that could create room for market manipulation or sanctions evasion. Bloomberg put HYPE’s market value at about $10.3 billion, making it the 13th largest crypto asset globally. Big enough to notice.
CME and ICE seem to want Hyperliquid moved toward registration with the Commodity Futures Trading Commission. That would quickly change the economics of on-chain perpetual futures. According to DefiLlama, Hyperliquid had about 70% of the on-chain perpetual futures market at its April 2025 peak. This is not a side project anymore. Why does this matter? Because CME and ICE can now argue that anonymous trading is not contained inside crypto; it could affect price discovery in markets beyond crypto, including oil.
The market did not shrug off the report as routine Washington noise. HYPE’s roughly 6% move from above $45 to below $43 was not a crash. Still, it showed traders are starting to price in regulatory risk. For BTC, ETH, and XRP traders, the issue is bigger than HYPE. If the CFTC starts pressuring on-chain derivatives venues, some liquidity could move toward regulated products, especially CME’s. Most guides frame this as a DeFi-versus-regulators story. That is only half right.
There is an awkward part here. I’ll be honest: CME’s position looks cleaner on paper than it feels in the market. CME is lobbying Washington while building out its own crypto derivatives lineup. Bitcoin Volatility Futures are scheduled to start trading on June 1. Nasdaq CME Crypto Index Futures are due on June 8. The index product includes BTC, ETH, XRP, and other assets, giving institutions a regulated way to trade broad crypto exposure.
The timing matters. CME’s push toward 24/7 crypto trading gives institutions something closer to the always-open markets that attracted users to venues like Hyperliquid in the first place. Hyperliquid offers spot and perpetual futures markets through a decentralized trading system built on its own layer 1 blockchain. It also has an order book exchange and HyperEVM infrastructure. Add lending, staking, governance, and other DeFi features. That is a lot of surface area for regulators to map.
Still, the legacy exchange argument is not only about protecting retail traders. Counter to the usual advice, this is not a story traders should reduce to “CME wants less competition.” CME and ICE are warning that rising crypto and commodity-linked trading volumes could affect price discovery in markets like oil, where global benchmarks matter. They say anonymous trading venues may give insiders or state-linked traders room to move prices. That framing is worth watching. It drags DeFi derivatives into sanctions and commodities policy, then into national security. Not just crypto compliance.
Hyperliquid is trying to answer the pressure. A person familiar with the discussions told Bloomberg that the Hyperliquid Policy Center, an advocacy group created in February by a Hyperliquid-affiliated foundation, has met with the CFTC about a possible legal structure for US users. US access would expand Hyperliquid’s retail market. The group says its markets offer more benefits and fewer risks than traditional centralized exchanges. I would not dismiss that claim, but Washington usually cares less about design elegance than control points.
The market question is blunt: will Washington treat Hyperliquid as a crypto experiment, or as a derivatives venue that needs CME-style safeguards? The answer could decide whether HYPE’s roughly $10.3 billion valuation gets a compliance premium or a regulatory haircut. Is this overkill? For a venue that reached about 70% of the on-chain perpetual futures market at its April 2025 peak, no. It may also change how traders value decentralized perpetual futures platforms that compete on speed and leverage. Transparency matters too. Lower compliance costs may be the part regulators attack first.
What this means
On-chain derivatives are now part of the legacy finance fight. Hyperliquid’s roughly 70% share of the on-chain perpetual futures market at its April 2025 peak made it too large for CME and ICE to ignore. HYPE is taking the first hit. The token is trading near its post-report range after falling from above $45 to below $43. Yes, this contradicts the easy “DeFi moves too fast for Washington” line. Bear with me: once CME and ICE make the case in Washington, speed becomes part of the risk argument.
Traders should watch two dates first: June 1, when CME Bitcoin Volatility Futures are scheduled to begin trading, and June 8, when Nasdaq CME Crypto Index Futures are set to launch with BTC, ETH, XRP, and other assets included. Those dates matter because regulated institutional products are arriving while Washington considers whether Hyperliquid should register with the CFTC. My read is simple: the next tell is whether HYPE stays below $43, or can push back above $45 as CME’s new crypto contracts go live.